Rod Krentel, MD
Radiation Oncology · Gulfport, MSNPI 1629060041
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $974 of the $1,274 with a category attached, or 76.4%. 11 manufacturers reported payments, led by Bayer at 35.5% of the total.
Across 49 payments — averaging $26.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$452
- Brainlab, Inc.$384
- Novartis$143
- Medtronic$82
- AstraZeneca$66
- Progenics Pharmaceuticals, Inc.$45
- plus $103 from 5 others
What the payments were for
- Travel & lodging$30024%
- Food & beverage$97476%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 24 | $452 |
| Brainlab, Inc. | 3 | $384 |
| Novartis | 8 | $143 |
| Medtronic | 4 | $82 |
| AstraZeneca | 3 | $66 |
| Progenics Pharmaceuticals, Inc. | 2 | $45 |
| Teleflex LLC | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Blue Earth Diagnostics | 1 | $21 |
| Dendreon Pharmaceuticals LLC | 1 | $17 |
| Siemens Medical Solutions USA, Inc. | 1 | $16 |
How this compares
$1,274 in reported general payments places this provider in the 65th percentile of 36 radiation oncology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 87 | $619 |
| Lidocaine Hcl ViscousLidocaine Hcl | 11 | $439 |
| Ondansetron Hcl | 11 | $356 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Gulfport
- Helen FosmireGulfport$35
- Jimmy CaudellJackson$17K
- Elbert DuncanTupelo$6K
- Micah MonaghanCorinth$5K
- Srinivasan VijayakumarJackson$5K
- Teessa Perekattu KuruvillaJackson$3K
- John CantrellOxford$3K
- Caleb DulaneyMeridian$2K
- Sophy ManganaHattiesburg$2K
- Naim SalloumHattiesburg$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.